Get the Stockscreener App
187.59
0.09%
0.175
Icon Plc stock is traded at $187.59, with a volume of 207.88K.
It is up +0.09% in the last 24 hours and up +2.60% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$187.42
Open:
$186.93
24h Volume:
207.88K
Relative Volume:
0.22
Market Cap:
$14.34B
Revenue:
$8.19B
Net Income/Loss:
$758.19M
P/E Ratio:
20.44
EPS:
9.18
Net Cash Flow:
$1.06B
1W Performance:
+6.24%
1M Performance:
+2.60%
6M Performance:
+0.31%
1Y Performance:
-7.25%
1-Day Range:
$186.93
$191.00
1-Week Range:
$175.18
$191.00
52-Week Range:
$125.10
$211.00
Icon Plc Stock (ICLR) Company Profile
Compare ICLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
187.82 | 14.31B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
624.79 | 235.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.43 | 167.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
697.94 | 55.72B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
241.85 | 40.77B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.51 | 38.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Downgrade | Truist | Buy → Hold |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
ICON expands oncology research with new cancer institute in Illinois By Investing.com - Investing.com Australia
Icon Plc $ICLR Shares Sold by Kornitzer Capital Management Inc. KS - MarketBeat
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership - Stock Titan
ICON plc (ICLR) Stock Analysis: A Strategic Look at the Healthcare Leader with a 10.54% Upside Potential - directorstalkinterviews.com
Parthenon LLC Increases Holdings in Icon Plc $ICLR - MarketBeat
Sector Gamma AS Acquires Shares of 24,967 Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Stock Position Increased by Hudson Edge Investment Partners Inc. - MarketBeat
ICON PLC (ICLR) Trades Below Normal Earnings Despite Strong Fundamentals - Insider Monkey
Icon PLC (ICLR) Shares Down 3.09% on Jan 20 - GuruFocus
Sumitomo Mitsui Trust Group Inc. Sells 22,687 Shares of Icon Plc $ICLR - MarketBeat
Fisher Funds Management LTD Has $75.44 Million Position in Icon Plc $ICLR - MarketBeat
Massachusetts Financial Services Co. MA Has $613.12 Million Stock Holdings in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Stake Boosted by Stephens Investment Management Group LLC - MarketBeat
SG Americas Securities LLC Sells 7,740 Shares of Icon Plc $ICLR - MarketBeat
Trinity Street Asset Management LLP Has $152.42 Million Stock Position in Icon Plc $ICLR - MarketBeat
Walter Public Investments Inc. Decreases Stake in Icon Plc $ICLR - MarketBeat
Does ICON (ICLR) Face a Deeper Credibility Test as Disclosure Risks Draw Fresh Scrutiny? - Sahm
ICON’s Role in Zealand Pharma’s Petrelintide Kidney Study: What Trial Completion Means for Investors - TipRanks
ICON plc (ICLR) Stock Analysis: A Strategic Healthcare Investment with 13.4% Upside Potential - DirectorsTalk Interviews
Icon Plc (NASDAQ:ICLR) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
San Bernardino Sun - FinancialContent
ICON plc’s Earnings Call: Balancing Growth and Challenges - MSN
Icon Energy Corp. (ICON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
ICON plc (ICLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Baird Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $217 - 富途资讯
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $216 - 富途牛牛
Rothschild Investment LLC Purchases New Position in Icon Plc $ICLR - MarketBeat
Demystifying Icon: Insights From 5 Analyst Reviews - Sahm
Icon (NASDAQ:ICLR) Shares Gap DownTime to Sell? - MarketBeat
Icon Plc $ICLR Shares Bought by Tributary Capital Management LLC - MarketBeat
Truist Financial Downgrades Icon PLC(ICLR.US) to Hold Rating, Announces Target Price $222 - 富途牛牛
Truist Securities downgrades ICON stock to Hold on growth concerns By Investing.com - Investing.com UK
Truist Securities downgrades ICON stock to Hold on growth concerns - Investing.com
[6-K] ICON PLC Current Report (Foreign Issuer) | ICLR SEC FilingForm 6-K - Stock Titan
Upcoming EventsICON plcOrdinary Shares (Nasdaq:ICLR) Detailed Stock Data - FinancialContent
SeaBridge Investment Advisors LLC Takes $2.59 Million Position in Icon Plc $ICLR - MarketBeat
ICLR stock touches 52-week low at $183.31 amid market challenges - MSN
ICON (ICLR) Is Up 8.0% After Artisan Flags Crisis-Level ValuationHas The Bull Case Changed? - simplywall.st
ICON Plc (ICLR) Investor Outlook: Analyzing Upside Potential And Market Position - DirectorsTalk Interviews
ICON plc Is Quietly Eating Wall Street: Is ICLR the Undervalued Game-Changer No One On TikTok Knows - AD HOC NEWS
Iqvia, Icon, Fortrea downgraded at Barclays on tariff overhang - MSN
Icon Plc $ICLR Shares Purchased by Ninety One UK Ltd - MarketBeat
Icon Plc $ICLR is Ninety One North America Inc.'s 9th Largest Position - MarketBeat
Eldred Rock Partners LLC Grows Stock Holdings in Icon Plc $ICLR - MarketBeat
Allspring Global Investments Holdings LLC Grows Stake in Icon Plc $ICLR - MarketBeat
Farmers & Merchants Investments Inc. Trims Stock Position in Icon Plc $ICLR - MarketBeat
Live Oak Private Wealth LLC Buys 5,593 Shares of Icon Plc $ICLR - MarketBeat
Rice Hall James & Associates LLC Purchases 9,889 Shares of Icon Plc $ICLR - MarketBeat
Swedbank AB Buys 6,300 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc (ICLR) Stock Price History & Data - Traders Union
Coho Partners Ltd. Has $26.69 Million Stock Holdings in Icon Plc $ICLR - MarketBeat
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):